National HealthCare Corporation (NHC) Cash Flow Statement

The wide oscillation in OCF/NI, from 0.37 to 2.65, suggests that net income is heavily influenced by non-cash items such as investment gains and losses, as well as timing of working capital. For instance, 2024Q3's low ratio coincides with a large acquisition outflow, while 2025Q2's high ratio reflects a substantial working capital release. Investors should normalize for these items to assess core cash generation.

The trajectory shows a clear recovery from the depressed FCF margins of early 2024, driven by revenue acceleration and stable capex intensity. The 2026Q2 FCF of $30.7M, though below the 2025Q3 peak of $56.5M, remains robust and supports continued dividend payments and strategic investments. The improvement is consistent with the income statement's operating leverage, but the lumpy working capital effects warrant monitoring.

NHC's capital expenditure intensity is low relative to its revenue, averaging around 2.5%, which is typical for a company that owns real estate but may understate the true maintenance needs of its facilities. The modest capex suggests that the company is not aggressively expanding its physical footprint, instead focusing on operational efficiency and higher-margin services like behavioral health. This conservative approach aligns with its fortress balance sheet but may limit organic growth potential.

The extreme volatility in working capital, particularly in accounts receivable and payable, is a key driver of the inconsistent OCF/NI ratios. For example, 2025Q4 saw a -$29.3M working capital drag, while 2025Q3 had a +$29.9M benefit, leading to FCF margins of 1.7% and 14.8% respectively. This pattern suggests that NHC's cash flow is heavily influenced by the timing of government reimbursements and vendor payments, which investors should factor into their models.

The company has maintained a steady dividend payout, which is well-covered by operating cash flow, and has opportunistically repurchased shares, particularly in 2026Q1. The $1.4B acquisition outflow in 2024Q3 indicates a significant strategic investment, likely in behavioral health, which may have temporarily reduced cash available for other uses. Overall, the deployment strategy appears balanced between returning cash to shareholders and investing in growth, though the large acquisition warrants scrutiny for integration and returns.

The cumulative OCF/NI ratio of 1.27 suggests that NHC's earnings quality is high, with cash flows consistently outpacing net income. This is partly due to non-cash charges like depreciation and amortization, but also reflects the company's ability to manage working capital effectively over time. However, the inclusion of investment gains in net income may inflate earnings, so the true operational cash conversion could be lower. Nonetheless, the positive divergence supports the fortress balance sheet and dividend sustainability.